Meta-analysis of cardiovascular outcome trials assessing the impact of glucagon-like peptide-1 receptor agonists on major cardiac arrhythmias.
Aristi BoulmpouDimitrios PatouliasChristodoulos E PapadopoulosEleftherios TeperikidisMichael DoumasVassilios VassilikosPublished in: Acta cardiologica (2022)
In patients with type 2 diabetes mellitus, treatment with GLP-1RAs does not significantly affect the risk for major cardiac arrhythmias.